Giovanni Li Volti reconfirmed director of CoEHAR
The CoEHAR Council (made up of 71 of the 95 members of the Center of Excellence of the University of Catania), meeting in an online session, reconfirmed their trust in…
CoEHAR teams up with US expert to refute ecig study
The COEHAR founder, prof. Riccardo Polosa, in collaboration with experts from US (Floe Foxon, Ray S. Niaura, K. Michael Cummings, Michael Siegel and Neal Benowitz) published a commentary to analyze data and methodologies used to support the paper’s conclusions.
BREAKTHROUGH STUDY REVEALS VARENICLINE AND COUNSELING EFFECTIVE FOR DUAL USERS IN SMOKING CESSATION
The study found that the antismoking medication varenicline can increase rates of smoking abstinence without causing serious adverse events.
CoEHAR: NO HEALTH RESPIRATORY EFFECTS REPORTED WITH ECIG SUBSTITUTION FOR SMOKING
In their work “Respiratory health effects of e-cigarette substitution for tobacco cigarettes: a systematic review”, researchers analyzed 16 studies from 20 publications: most of the studies showed no difference in respiratory parameters. This indicates that electronic nicotine delivery systems substitution for smoking likely does not result in additional harm to respiratory health.
REPLICA STUDY: CoEHAR research shows minimal to zero cancerogenic effects of e-cigarettes
Replica researchers performed a standard toxicology battery of three assays used for product assessment and regulatory applications.
Cochrane: Some medicines and e-cigarettes can help people to quit smoking
According the authors, for every 100 people, 10 to 19 are likely to quit using an e-cigarette; 12 to 16 using varenicline; and 10 to 18 using cytisine. This is compared to the 6 in 100 people likely to quit when using no medicine/e-cigarette or placebo. People using two forms of nicotine replacement therapy at the same time, for example, a combination of nicotine patch and nicotine gum, seemed to have similar rates of quitting to people using e-cigarettes, varenicline and cytisine.
Letter to the Editors of Substance Abuse: vaping and youths researches
According to prof. Riccardo Polosa, CoEHAR founder: "This small qualitative research simply found what we already knew: that young people are eager to explore new experiences, with vaping potentially being one of them. A critical limitation of this research is the absence of insights into how these participants have been educated about the health implications and addictive nature of nicotine/vaping. To work towards a smoke-free world, it's essential that our messaging on vaping's risk-to-benefit ratio is both accurate and truthful"
CoEHAR members raised concerns on South Africa drafted bill on smoking
"We read with interest the proposed draft bill and we are appreciative of the key contributions this Bill will make in relation to the contrast of tobacco smoking. However, we are concerned that the current draft will restrict less risky options for people who would benefit from using these products to quit smoking. Bringing regulatory parity between cigarettes and non-combustible alternatives (like e-cigarettes, heated tobacco products, oral nicotine/tobacco pouches) will further discourage smokers from trying alternatives – something that should be actively encouraged given that South Africa has high smoking prevalence and low successful quitting rate"
Doctors’ Survey: Italy results
86% of physicians believe that combustion is more harmful than nicotine. 64%-77% of physicians believe that nicotine directly causes various smoking-related conditions, with 19% to 32% believing strongly.
Doctors Survey: international webinar
A panel of tobacco control experts, including Dr. Sudhanshu Patwardhan, Dr. Riccardo Polosa, and Dr. Jed Rose, discuss their views on how the survey results might impact smoking cessation and tobacco harm reduction efforts.
